다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NYSE
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT) 뉴스

ADCT

ADC Therapeutics (ADCT)

ADC Therapeutics SA

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:ADCT

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/09	05:07	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/05/08	05:06	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:ADCT	ADC Therapeutics SA
2024/05/08	05:02	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	20:30	GlobeNewswire Inc.	ADC Therapeutics Announces $105 Million Underwritten Offering of Common Shares and Pre-Funded Warrants	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	19:51	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	19:38	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	19:29	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	19:10	GlobeNewswire Inc.	ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates	NYSE:ADCT	ADC Therapeutics SA
2024/05/06	19:00	GlobeNewswire Inc.	ADC Therapeutics Announces Initial Data from Investigator-Initiated Phase 2 Clinical Trial of ZYNLONTA® in Patients with Relapsed/Refractory Marginal Zone Lymphoma	NYSE:ADCT	ADC Therapeutics SA
2024/05/02	05:05	GlobeNewswire Inc.	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	NYSE:ADCT	ADC Therapeutics SA
2024/05/01	20:00	GlobeNewswire Inc.	ADC Therapeutics to Host First Quarter 2024 Financial Results and Pipeline Update Conference Call on May 6, 2024	NYSE:ADCT	ADC Therapeutics SA
2024/04/04	20:00	GlobeNewswire Inc.	ADC Therapeutics Announces Updates on LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Glofitamab or Mosunetuzumab in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma	NYSE:ADCT	ADC Therapeutics SA
2024/04/03	20:00	GlobeNewswire Inc.	ADC Therapeutics to Host a Virtual Research Investor Event on Tuesday, April 9, 2024	NYSE:ADCT	ADC Therapeutics SA
2024/04/02	05:05	GlobeNewswire Inc.	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	NYSE:ADCT	ADC Therapeutics SA
2024/03/13	20:03	IH Market News	Mixed Futures Amidst Quiet Economic Schedule; Oil Prices Climb	NYSE:ADCT	ADC Therapeutics SA
2024/03/13	20:00	GlobeNewswire Inc.	ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates	NYSE:ADCT	ADC Therapeutics SA
2024/03/06	21:15	GlobeNewswire Inc.	ADC Therapeutics to Participate in the Guggenheim 5th Annual Healthy Altitudes Summit	NYSE:ADCT	ADC Therapeutics SA
2024/03/06	21:00	GlobeNewswire Inc.	ADC Therapeutics to Host Fourth Quarter and Year-End 2023 Financial Results Conference Call on March 13, 2024	NYSE:ADCT	ADC Therapeutics SA
2024/03/06	07:45	GlobeNewswire Inc.	ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research (AACR) Annual Meeting	NYSE:ADCT	ADC Therapeutics SA
2024/03/05	23:15	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/03/01	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/02/27	21:00	GlobeNewswire Inc.	ADC Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	NYSE:ADCT	ADC Therapeutics SA
2024/01/24	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/01/20	06:30	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/01/04	21:15	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/01/04	21:15	GlobeNewswire Inc.	ADC Therapeutics Regains Compliance with NYSE Continued Listing Standards	NYSE:ADCT	ADC Therapeutics SA
2024/01/04	21:00	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/01/04	21:00	GlobeNewswire Inc.	ADC Therapeutics Provides Business Updates	NYSE:ADCT	ADC Therapeutics SA
2024/01/03	10:10	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/01/03	10:05	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA

검색 관련기사 보기:NYSE:ADCT

1 2 3 4 5 6 7 8 9 10 다음 >>

Bank of America

Health Care Select Sector

Verizon Communications

Gold vs US Dollar

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

US Dollar vs Sterling

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관